Insider trading

Period: 12 months + Add filter
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

60,018 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

60,018 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

60,018 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

60,018 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
60,018 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
60,018 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

60,018 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
19 Mar 2026
Hair Cara M. SVP, CORP. SERVICES & CLO
Sold at will
$2.15M 58,771 at 36.62
25.1%
Not planned
19 Mar 2026
Sold on a plan 4×
$2.11M 10,000 at 210.90
0.5%
Planned (10b5-1)
19 Mar 2026
Slootman Frank Director
Sold on a plan
$1.98M 11,299 at 175.25
22.9%
Planned (10b5-1)
19 Mar 2026
Potter Jason J. N. President and CEO
Bought
$1.69M 286,097 at 5.90
99.2%
First buy on file
19 Mar 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$1.66M 64,533 at 25.69
45.1%
Planned (10b5-1)
19 Mar 2026
Klein Rosemary L SVP, CLO & Corp. Sec.
Sold at will 2×
$1.60M 15,000 at 106.87
21.8%
Not planned
19 Mar 2026
Furner John R. President & CEO
Sold on a plan
$1.60M 13,125 at 121.96
1.9%
Planned (10b5-1)
19 Mar 2026
Stevens David Todd Chief Capital Officer
Sold on a plan 3×
$1.59M 49,708 at 32.02
10.2%
Planned (10b5-1)
19 Mar 2026
Lewis William Chair and CEO
Sold on a plan 3×
$1.54M 10,699 at 143.52
3.4%
Planned (10b5-1)
19 Mar 2026
Framework Ventures IV L.P. 10% owner · indirect
Bought
$1.51M 53,000 at 28.48
6.2%
Largest buy in 3 yrs
19 Mar 2026
Eckert Kurt M. Director
Sold on a plan
$1.48M 37,917 at 39.00
21.0%
Planned (10b5-1)
19 Mar 2026
BOSCH MARIANO Chief Executive Officer
Sold at will
$1.45M 100,000 at 14.50
10.0%
Not planned
19 Mar 2026
Kelleher Eric Robert See Remarks
Sold on a plan
$1.35M 16,818 at 80.00
52.1%
Sold half or more
19 Mar 2026
Wu Lei Chief Executive Officer · indirect
Sold on a plan 2×
$1.14M 27,519 at 41.26
22.9%
Planned (10b5-1)
19 Mar 2026
Japan Post Holdings Co., Ltd. 10% owner · indirect
Sold on a plan 2×
$1.08M 10,100 at 107.41
0.0%
Planned (10b5-1)
19 Mar 2026
Mindlin Damian Miguel Vice President
Sold at will
$1.02M 300,000 at 3.41
2.0%
Not planned
19 Mar 2026
Lambert Danielle Director · indirect
Bought
$1,000.00K 84,602 at 11.82
opened
First buy on file
19 Mar 2026
Sorensen Alma Gregory Chief Strategy Officer
Sold at will 3×
$933.01K 15,000 at 62.20
1.2%
Not planned
19 Mar 2026
Larkin Kyle T President & CEO
Sold on a plan
$876.51K 7,314 at 119.84
3.9%
Planned (10b5-1)
19 Mar 2026
Ye Gang COO · indirect
Sold on a plan
$817.20K 10,000 at 81.72
12.5%
Planned (10b5-1)
19 Mar 2026
Azamian Bobak R. President/CEO and Board Chair
Sold at will
$801.59K 11,964 at 67.00
26.4%
Not planned
19 Mar 2026
Buhigas Pedro R. Chief Information Officer
Sold on a plan
$776.99K 13,942 at 55.73
24.6%
Planned (10b5-1)
19 Mar 2026
Moura Timothy See Remarks
Sold on a plan 2×
$775.76K 29,133 at 26.63
12.2%
Planned (10b5-1)
19 Mar 2026
Tobin Regina A. PRESIDENT
Sold at will
$760.95K 4,450 at 171.00
24.4%
Not planned
19 Mar 2026
SHUSTER BRADLEY M Executive Chairman
Sold at will
$703.89K 18,996 at 37.05
4.4%
Not planned
19 Mar 2026
Tricio Haro Eduardo Director · indirect
Bought
$660.00K 500,000 at 1.32
opened
First buy on file
19 Mar 2026
Bought
$660.00K 500,000 at 1.32
3.4%
First buy on file
19 Mar 2026
Steimer Olivier Director
Sold at will
$658.60K 2,000 at 329.30
7.3%
Not planned
19 Mar 2026
Barbosa Rodrigo Cardoso President and CEO
Sold at will
$658.18K 10,000 at 65.82
1.1%
Not planned
19 Mar 2026
Sold at will
$643.89K 6,669 at 96.55
17.8%
Not planned
19 Mar 2026
Chernett Jorey 10% owner
Bought
$598.50K 450,000 at 1.33
5.5%
19 Mar 2026
Hulls Chris Director
Sold on a plan
$596.69K 15,133 at 39.43
4.3%
Planned (10b5-1)
19 Mar 2026
SARVADI PAUL J Chairman of the Board & CEO · indirect
Bought 2×
$589.97K 25,000 at 23.60
2.6%
19 Mar 2026
Janssen Ann D. EVP & Chief Financial Officer
Sold at will
$582.71K 4,161 at 140.04
4.0%
Not planned
19 Mar 2026
Aldeco Marcelo Gustavo Labor Relations VP
Sold at will
$554.68K 12,719 at 43.61
99.2%
Sold half or more
19 Mar 2026
Sold at will
$552.35K 52,316 at 10.56
3.5%
Not planned
19 Mar 2026
Sold on a plan
$528.00K 12,000 at 44.00
7.4%
Planned (10b5-1)
19 Mar 2026
ZISES SELIG Director · indirect
Sold at will 2×
$525.50K 5,000 at 105.10
43.5%
Not planned
19 Mar 2026
ALBER LAURA Director
Bought 2×
$500.27K 2,571 at 194.58
36.9%
First buy on file
19 Mar 2026
Dhanasekaran Satish President and CEO
Sold at will
$483.43K 1,667 at 290.00
1.3%
Not planned
19 Mar 2026
Madan Gopal Ajay Chief Financial Officer
Sold at will
$479.22K 51,585 at 9.29
4.2%
Not planned
19 Mar 2026
Goldberg Scott L. President, Consumer Division
Sold on a plan
$442.08K 11,060 at 39.97
4.9%
Planned (10b5-1)
19 Mar 2026
Sold at will
$437.61K 8,083 at 54.14
1.0%
Not planned
19 Mar 2026
Zhao Peng Jonathan Chief Executive Officer · indirect
Sold on a plan
$431.71K 64,000 at 6.75
11.1%
Planned (10b5-1)
19 Mar 2026
Schneider Eugene EVP, Chf Clinical Develop Ofcr
Sold on a plan
$412.49K 5,812 at 70.97
8.3%
Planned (10b5-1)
19 Mar 2026
Van Nieuwenhuyse Rick President & CEO
Sold at will
$387.45K 21,621 at 17.92
4.0%
Not planned
19 Mar 2026
Moore Michael President · indirect
Sold at will
$370.54K 40,232 at 9.21
2.4%
Not planned
19 Mar 2026
BENDHEIM JACK President and CEO · indirect
Sold on a plan 3×
$369.73K 7,040 at 52.52
8.8%
Planned (10b5-1)
19 Mar 2026
Lee Kang Jyh Director
Sold at will
$358.00K 10,000 at 35.80
2.4%
Not planned
19 Mar 2026
Sold at will
$354.10K 648,767 at 0.55
100%
Sold half or more
Showing 33,651–33,700 of 60,018. ← Newer Page 674 of 1,201 Older →